Conference Session Tracks

This session will explore the latest techniques in molecular diagnostics that enhance the detection of fungal pathogens. Emphasis will be placed on the integration of innovative technologies in clinical settings.

SDG 3 SDG 4

This track focuses on the complex interactions between fungal pathogens and their hosts, highlighting mechanisms of infection and immune response. Research findings will be presented that elucidate the pathophysiology of fungal diseases.

SDG 3 SDG 4

This session will address the growing concern of antimicrobial resistance among fungal pathogens. Discussions will include mechanisms of resistance and strategies for overcoming these challenges in clinical practice.

SDG 3 SDG 9

This track will present recent clinical research findings related to the diagnosis, treatment, and management of fungal diseases. Participants will engage in discussions about the implications of these findings for patient care.

SDG 3 SDG 4

This session aims to bridge the gap between laboratory research and clinical application in the field of mycology. Presentations will focus on translating scientific discoveries into effective therapeutic strategies.

SDG 3 SDG 9

This track will showcase cutting-edge laboratory techniques that enhance the study of fungal pathogens. Participants will learn about novel methodologies that improve accuracy and efficiency in mycological research.

SDG 3 SDG 4

This session will explore the development of new antifungal agents and therapeutic strategies. Discussions will include the challenges and opportunities in the field of fungal therapeutics.

SDG 3 SDG 4

This track will highlight innovative approaches to managing fungal diseases through microbial interventions. Presentations will cover the role of probiotics and other microbial agents in enhancing health outcomes.

SDG 3 SDG 4

This session will focus on the epidemiological trends of fungal infections globally. Participants will discuss factors contributing to the rise in incidence and prevalence of these diseases.

SDG 3 SDG 9

This track will address the unique challenges posed by fungal infections in immunocompromised populations. Research will be presented on prevention, diagnosis, and treatment strategies tailored for these vulnerable groups.

SDG 3 SDG 4

This session will provide insights into the future directions of research and clinical practice in mycology. Experts will discuss emerging trends and potential breakthroughs in the understanding and treatment of fungal diseases.

SDG 3 SDG 4